BioSpace News Archive

PharmaMar (MCE: PHM) has presented data during the International Association for the Study of Lung Cancer (IASLC 2018), that is taking place from the 23rd to the 26th of September in Toronto (Canada), on Overall Survival (OS) from the Phase I/II Study of lurbinectedin in combination with doxorubicin for relapsed small cell lung cancer.

Accelerating Wireless Broadband Deployment by Removing Barriers To Infrastructure Investment Order will be voted on Wednesday by FCC denying citizens and local government the right to stop 5G cell tower transmitters in front of their homes.

A Foundation created in honor of Sandy Hook School victim, Avielle Richman, funds violence prevention research. Founder and CEO Dr. Richman said, “Following Avielle’s murder, we needed to find a purpose to get out of bed, to navigate our new reality without our beautiful little girl.

Astellas Farma Brasil (AFB) was recently named one of the Best Pharmaceutical Companies To Work For in Brazil according to Great Place to Work® Institute’s latest ranking. This marks the fifth consecutive year AFB has been recognized as a top pharmaceutical company in Brazil.

MEDISCA strives to proactively strengthen their quality systems and adhere to regulatory requirements and enforcement.

Elanco Animal Health Incorporated today announced the closing of its previously announced initial public offering (“IPO”) of 62.9 million shares of its common stock at a price to the public of $24.00 per share.

Med-X, Inc.'s green pesticide product division, Nature-Cide, announced today that it has signed a direct distribution deal with one of the nation’s leading green-focused pest control service companies, Pestmaster Services.

Demerger clears the path for therapeutic company capital raising

At its 2018 awards gala, BioAlberta, the province’s life sciences industry association, recognized two leaders for their innovation and achievements. BioAlberta congratulates Circle Cardiovascular Imaging Inc. for winning its Company of the Year award and Dr. John Lewis for winning its Scientific Achievement and Innovation Award.

Technavio has announced their latest drug pipeline analysis report on diabetic retinopathy. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of diabetic retinopathy.